Skip Navigation
< Back
QualityTool

American Society of Clinical Oncology (ASCO) Patient Guide: Hormone Therapy for Advanced Prostate Cancer


Description

This patient guide summarizes the American Society of Clinical Oncology's recommendations on hormone therapy for men with advanced prostate cancer.

This patient guide addresses the following topics:

  • Recommendations
  • What this means for patients
  • Questions to ask the doctor

Developer

American Society of Clinical Oncology

Funding Sources

American Society of Clinical Oncology


QualityTool Topic

Disease/Condition-Related; Guideline-Related


Links to National Guideline Clearinghouse or National Quality Measures Clearinghouse:

This tool is derived from the following guideline in the National Guideline Clearinghouse (NGC): Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline:
http://www.guideline.gov/summary/summary.aspx?ss=15&doc_id=10808&string=

History

  • Release Date: 04/2007
  • Original Summary: 07/2007
Disclaimer: The inclusion of a tool in the Innovations Exchange does not constitute or imply an endorsement by the U.S. Department of Health and Human Services, the Agency for Healthcare Research and Quality or Westat of the tool or of the submitter or developer of the tool. Read more.
QualityTool Classification

Patient Population:
Stage of Care:
IOM Domains of Quality:
QualityTool Format:

Last updated: September 12, 2012.